|
Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective
K Ghosh
Fmr. Director, National Institute of Immunohaematology, KEM Hospital, Parel, Mumbai, Maharashtra, India
Correspondence Address:
K Ghosh
Fmr. Director, National Institute of Immunohaematology, KEM Hospital, Parel, Mumbai, Maharashtra
India
How to cite this article:
Ghosh K. Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective.J Postgrad Med 2022;68:70-71
|
How to cite this URL:
Ghosh K. Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective. J Postgrad Med [serial online] 2022 [cited 2022 Aug 8 ];68:70-71
Available from: https://www.jpgmonline.com/article.asp?issn=0022-3859;year=2022;volume=68;issue=2;spage=70;epage=71;aulast=Ghosh;type=0 |
|
|
|
